Lotte Biologics, Axcelead Drug Discovery Partners, Inc., and Kanaph Therapeutics Inc. have signed a tripartite Memorandu...
South Korea-based Samsung Biologics, a leading contract development and manufacturing organisation (CDMO), has announced...
South Korea-based Mezzion Pharma Co., a leader in rare disease therapeutics, has announced the expansion of its udenafil...
Cytiva, a Danaher company and global life sciences leader, has completed significant expansion projects in several locat...
Swedish biotech company Salipro Biotech AB has entered into a research collaboration with South Korea headquartered Daew...
AriBio Co., a South Korean biopharmaceutical company specialising in neurodegenerative diseases, and a Swiss pharmaceuti...
US-based Seer, Inc. and Korea University have announced the launch of a population-level study aimed at identifying nove...
MarkHerz Inc., a South Korea-based biotechnology startup specialising in AAV-based gene therapies targeting cardiovascul...
Bio-healthcare company Dx&Vx (DXVX) has accelerated the development program for a universal COVID-19 vacci...
US-based BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, has a...
It was a privilege to share BioSpectrum Asia’s vision and editorial focus with AVING News during ICPI Week 2025 in...
ICPI Week 2025 Wrap-Up ICPI WEEK 2025 WRAP-UP | BY MANBEENA CHAWLA, EXECUTIVE EDITOR, BIOSPECTRUM ASIA ...
MediThinQ, the South Korean startup specialising in wearable extended reality (XR) surgical displays, has announced a st...
The Ministry of Health and Welfare (MoHW), South Korea government and the National Institute for Korean M...
Thermo Fisher recently celebrated the opening of its new Cell and Gene Therapy (CGT) Vision Centre in South Korea. The c...
Rznomics Inc., a South Korea-based biopharmaceutical startup specialising in RNA-based therapeutics, has entered in...
US-based TriLink BioTechnologies, a Maravai LifeSciences company and global provider of life science reagents and s...
Agilent Technologies Inc. has signed a Memorandum of Understanding (MoU) with Ubix Therapeutics to accelerate highly tar...
